Status:
COMPLETED
oVRcome Self-guided Virtual Reality for Specific Phobias
Lead Sponsor:
University of Otago
Collaborating Sponsors:
oVRcome
Conditions:
Specific Phobia
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Specific phobias: fear of flying, heights, spiders, dogs and needles are the extremely common and exposure therapy (ET) is the first line of treatment. Using Virtual Reality (VR), participants will ha...
Eligibility Criteria
Inclusion
- In order to be eligible to participate in this study, a subject must meet all of the following criteria:
- are between 18-64 years old
- Have a fear of flying, heights, spiders, dogs, needles and score above 4 on the Brief Standard Self rating scale for phobic patients (Marks, I. Matthews ,A (1979) Behaviour Research and Therapy)
- have access to a smart phone and internet
- willing to participate in the research study and providing informed consent
Exclusion
- A potential subject who meets any of the following criteria will be excluded from participation in this study:
- present with symptoms of severe depression or suicidality respectively as measured with the PHQ-9; total score \> 19
- have insufficient knowledge of the English language
- are under current treatment for specific phobia or psychotropic medication (unless on stable dosage for the previous 3 months and no changes planned during the study period).
Key Trial Info
Start Date :
June 2 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 7 2022
Estimated Enrollment :
126 Patients enrolled
Trial Details
Trial ID
NCT04909177
Start Date
June 2 2021
End Date
March 7 2022
Last Update
August 22 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Otago, Christchurch
Christchurch, Canterbury, New Zealand, 8011